A model for teaching bedside detection of glass in wounds

por Levine, Matthew R, Gorman, Stephen M, Yarnold, Paul R
Publicado 2007

Case of fatal familial insomnia caused by a d178n mutation with phenotypic similarity to Hashimoto’s encephalopathy

por Stevens, Jessica M, Levine, Matthew R, Constantino, Anne E, Motamedi, Gholam K
Publicado en BMJ Case Rep (2018)

Correlated activity supports efficient cortical processing

por Hung, Chou P., Cui, Ding, Chen, Yueh-peng, Lin, Chia-pei, Levine, Matthew R.
Publicado en Front Comput Neurosci (2015)

Corrigendum: Correlated activity supports efficient cortical processing

por Hung, Chou P., Cui, Ding, Chen, Yueh-peng, Lin, Chia-pei, Levine, Matthew R.
Publicado en Front Comput Neurosci (2015)

Serum C-telopeptide collagen crosslinks and plasma soluble VEGFR2 as pharmacodynamic biomarkers in a trial of sequentially administered sunitinib and cilengitide

por O’Donnell, Peter H., Karovic, Sanja, Karrison, Theodore G., Janisch, Linda, Levine, Matthew R., Harris, Pamela J., Polite, Blase N., Cohen, Ezra E.W., Fleming, Gini F., Ratain, Mark J., Maitland, Michael L.
Publicado en Clin Cancer Res (2015)

Sorafenib Dose Escalation is Not Uniformly Associated with Blood Pressure Elevations in Normotensive Patients with Advanced Malignancies

por Karovic, Sanja, Wen, Yujia, Karrison, Theodore G., Bakris, George L., Levine, Matthew R., House, Larry K., Wu, Kehua, Thomeas, Vasiliki, Rudek, Michelle A., Wright, John J., Cohen, Ezra E.W., Fleming, Gini F., Ratain, Mark J., Maitland, Michael L.
Publicado 2014

Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small...

por Maitland, Michael L, Levine, Matthew R, Lacouture, Mario E, Wroblewski, Kristen E, Chung, Christine H, Gordon, Ilyssa O, Szeto, Livia, Ratko, Gail, Soltani, Keyoumars, Kozloff, Mark F, Hoffman, Philip C, Salgia, Ravi, Carbone, David P, Karrison, Theodore G, Vokes, Everett E
Publicado 2014

Identification of a variant in KDR associated with serum VEGFR2 and pharmacodynamics of pazopanib

por Maitland, Michael L., Xu, Chun-Fang, Cheng, Yu-Ching, Kistner-Griffin, Emily, Ryan, Kathleen A., Karrison, Theodore G., Das, Soma, Torgerson, Dara, Gamazon, Eric, Thomeas, Vasiliki, Levine, Matthew R., Wilson, Paul A., Bing, Nan, Liu, Yuan, Cardon, Lon R., Pandite, Lini N., O’Connell, Jeffrey R., Cox, Nancy J., Mitchell, Braxton D., Ratain, Mark J., Shuldiner, Alan R.
Publicado en Clin Cancer Res (2014)